Tag: iShares U.S. Pharmaceuticals ETF

India is launching cheap, weight-loss drugs and Novo Nordisk is betting on its brands to stay on top

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share

Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

Eli Lilly shares slide after a bearish Wall Street analyst call — here’s our view

Hims & Hers shares surge 50% after Novo Nordisk drops patent infringement case over compounded weight loss drugs

Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.

Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly

Novartis, Genentech file suit alleging illegal importation of prescription drug

Healthy Returns: What’s next for Novo Nordisk’s next-generation obesity drug CagriSema after trial miss